Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Patient Education and Counseling|February 5, 2026
Adapting mainstreaming genetic education and clinical communication materials for cancer patients of varying backgroundsStephanie N Christian-Afflu, Rania Sheikh, Anna Strang, et al.
The Journal of Urology|March 28, 2023
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer PatientsKelsey E Breen, Heather Symecko, Kelsey Spielman, et al.
Journal of Genetic Counseling|October 14, 2016
Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support GroupMarina J Corines, Jada G Hamilton, Emily Glogowski, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
NPJ Breast Cancer|January 29, 2026
Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapyLuc Cabel, Julia Ah-Reum An, Hong-Kyu Kim, et al.
Cancer|October 7, 2015
Identification of germline genetic mutations in patients with pancreatic cancerErin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Nature Genetics|July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancersCraig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2025
KEYLYNK-009: Pembrolizumab Plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer and Clinical Benefit From First-Line Pembrolizumab Plus ChemotherapyHope S Rugo, David W Cescon, Mark E Robson, et al.
Pageof 18